Replacing the Anthracycline By Gemtuzumab Ozogamicin in Older Patients with De Novo Standard-Risk Acute Myeloid Leukemia Treated Intensively - Results of the Randomized ALFA1401-Mylofrance 4 StudyJuliette Lambert,Jérôme Lambert,Emilie Lemasle,Magalie Joris,Sylvain Chantepie,Cecile Pautas,Xavier Thomas,Jean Valere Malfuson,Lauris Gastaud,Denis Caillot,Emmanuelle Tavernier,Pascal Turlure,Diana Carp,Celine Berthon,Olivier Legrand,Ambroise Marçais,Iona Vaida,Sarah Barbieux,Philippe Rousselot,Claude GardinBlood(2021)引用 3|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要